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Abstract
Background: Severe and cerebral malaria are associated with endothelial activation. Angiopoietin-1 (ANG-1)
and angiopoietin-2 (ANG-2) are major regulators of endothelial activation and integrity. The aim of this study was
to investigate the clinical utility of whole blood angiopoietin (ANG) levels as biomarkers of disease severity in
Plasmodium falciparum malaria.
Methods: The utility of whole blood ANG levels was examined in Thai patients to distinguish cerebral (CM; n =
87) and severe (non-cerebral) malaria (SM; n = 36) from uncomplicated malaria (UM; n = 70). Comparative
statistics are reported using a non-parametric univariate analysis (Kruskal-Wallis test or Chi-squared test, as
appropriate). Multivariate binary logistic regression was used to examine differences in whole blood protein levels
between groups (UM, SM, CM), adjusting for differences due to ethnicity, age, parasitaemia and sex. Receiver
operating characteristic curve analysis was used to assess the diagnostic accuracy of the ANGs in their ability to
distinguish between UM, SM and CM. Cumulative organ injury scores were obtained for patients with severe
disease based on the presence of acute renal failure, jaundice, severe anaemia, circulatory collapse or coma.
Results: ANG-1 and ANG-2 were readily detectable in whole blood. Compared to UM there were significant
decreases in ANG-1 (p < 0.001) and significant increases in ANG-2 (p < 0.001) levels and the ratio of ANG-2:
ANG-1 (p < 0.001) observed in patients with SM and CM. This effect was independent of covariates (ethnicity,
age, parasitaemia, sex). Further, there was a significant decrease in ANG-1 levels in patients with SM (non-
cerebral) versus CM (p < 0.001). In participants with severe disease, ANG-2, but not ANG-1, levels correlated
with cumulative organ injury scores; however, ANG-1 correlated with the presence of renal dysfunction and
coma. Receiver operating characteristic curve analysis demonstrated that the level of ANG-1, the level of ANG-
2 or the ratio of ANG-2: ANG-1 discriminated between individuals with UM and SM (area under the curve, p-
value: ANG-2, 0.763, p < 0.001; ANG-1, 0.884, p < 0.001; Ratio, 0.857, p < 0.001) or UM and CM (area under
the curve, p-value: ANG-2, 0.772, p < 0.001; ANG-1, 0.778, p < 0.001; Ratio, 0.820, p < 0.001).
Conclusions: These results suggest that whole blood ANG-1/2 levels are promising clinically informative
biomarkers of disease severity in malarial syndromes.
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Background
Only a small proportion of individuals with Plasmodium
falciparum malaria progress to severe and potentially fatal
forms of infection [1,2]. The definitive diagnosis of severe
and cerebral malaria is challenging due to the non-specific
nature of the clinical presentation and the confounder of
incidental parasitaemia in malaria-endemic areas [3].
These factors may result in misdiagnosis and adverse out-
comes due to the failure to treat other life-threatening
infections [2,3]. In studies of African children diagnosed
with cerebral malaria, over 20% were shown to have an
alternative cause for their neurological syndrome at post-
mortem examination [3]. A rapid point-of-care test that
accurately identifies patients with severe or cerebral
malaria, or those at risk of progressing to these syn-
dromes, would be of clinical and public health utility.
However, limited prognostic or diagnostic laboratory
tools for severe malaria are currently available.
Endothelial activation and dysfunction have been impli-
cated in the pathogenesis of severe and cerebral malaria
[4-11]. The angiogenic factors, angiopoietin-1 (ANG-1)
and angiopoietin-2 (ANG-2) have recently been shown to
function as essential regulators of endothelial activation
and integrity [12]. ANG-1 is constitutively expressed and
maintains vascular quiescence by signaling though the
Tie-2 receptor [12]. ANG-2 is released from Weibel-Palade
(WP) bodies in association with endothelial activation
and displaces ANG-1; sensitizing the endothelium to
become responsive to sub-threshold concentrations of
cytokines such as TNF [12]. Elevations in plasma or serum
ANG-2 levels have been reported in patients with sepsis,
acute lung injury/acute respiratory distress syndrome
[13,14], and severe malaria [8,11].
Based on the hypothesis that dysregulation of angiopoie-
tins is associated with severe malaria syndromes, ANG-1
and ANG-2 levels were examined in malaria-infected
patients to determine if they would distinguish between
uncomplicated, severe and cerebral malaria. This study
focused on the predictive value of ANG-1 and ANG-2 lev-
els in whole blood, since unprocessed whole blood
obtained by finger prick is a preferred clinical specimen
for point-of-care testing [15].
Methods
Study population and specimen collection
Individuals (≥ 13 years of age) presenting with falciparum
malaria to Hospital for Tropical Disease clinics (Mahidol
University, Thailand) were eligible for enrolment into this
study. Patients were classified into uncomplicated (UM),
cerebral (CM) or severe (non-cerebral) malaria (SM)
according to WHO criteria [2]. Whole blood samples (pre-
treatment) were collected from all patients for thick and
thin blood film preparation, PCR, and complete blood
counts. A heparinized aliquot was frozen at -80°C for
determination of subsequent angiopoietin levels. An
expert microscopist, who was blinded to the results of
additional diagnostic testing, examined the blood films.
Smears were considered negative if no parasites were seen
in two consecutive thick blood films. Parasite density was
calculated by thick or thin film determining the number
of parasites per 200 white blood cells for thick blood films
or per 1,000 red blood cells (RBC) for thin blood films.
Baseline white blood cell counts or RBC counts were used
to calculate parasitaemia (parasites per μL). Plasmodium
falciparum diagnosis was confirmed by PCR as previously
described [16]. The institutional review board of the Fac-
ulty of Tropical Medicine, Mahidol University approved
this study and informed consent was obtained from all
patients or their legal guardians prior to specimen collec-
tion.
Quantification of ANG-1 and ANG-2 in whole blood
Whole blood concentrations of ANG-1 and ANG-2 were
measured by ELISA (R&D Systems, Minneapolis MN)
according to the manufacturers' instructions. Concentra-
tions were interpolated from 4-parameter-fit standard
curves generated using a standard curve of recombinant
human angiopoietin proteins. The lower and upper limits
of detection for each assay were as follows: ANG-1
(156.25 - 10,000 pg/mL) and ANG-2 (54.69 - 3,500 pg/
mL).
Statistical analyses
Statistical analysis was performed using SPSS v17.0. Com-
parative statistics are reported from a non-parametric uni-
variate analysis (Kruskal-Wallis test, followed by Mann-
Whitney U test with adjustment for multiple comparisons
or Chi-squared test, as appropriate). Multivariate binary
logistic regression was used to examine differences in
whole blood protein levels between groups (UM, SM,
CM), adjusting for differences due to ethnicity, age, para-
sitaemia and sex. Spearman's correlation was used to
examine correlations between angiopoietin levels and
parasitaemia or cumulative organ injury scores. Receiver
operating characteristic (ROC) curves and area under the
ROC curves were generated using SPSS v.17.0. Optimal
test thresholds were derived mathematically from the
ROC curves. To adjust for multiple comparisons at a fam-
ily-wise simultaneous error rate of α = 0.05, Bonferonni
corrections were applied as appropriate.
Results
Study population
193 patients with P. falciparum malaria were enrolled dur-
ing the study. Patients were classified as having UM, (n =
70), SM (n = 36) or CM (n = 87) [2]. In patients with com-
plicated disease (SM and CM), 22 participants (17.9%)
had evidence of acute renal failure, 71 had evidence of
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liver dysfunction (57.7%), three had algid malaria with a
systolic blood pressure less than 80 mmHg (2.4%), 34
were anaemic and required a blood transfusion (27.6%)
and 87 were in a coma (70.7%). Of study participants
with severe malaria, 46 had a single organ system
involved, 41 had two organ systems affected, 22 had three
and five patients had involvement of four organ systems.
There was a single fatality in the study with the study par-
ticipant having cerebral malaria and algid malaria. Demo-
graphic and baseline clinical characteristics of the study
participants are shown in Table 1.
Whole blood ANG-2 levels are increased and ANG-1 levels 
are decreased in SM or CM compared to UM
Whole blood ANG-2 levels were significantly higher in
individuals with SM or CM compared to individuals with
UM (Figure 1A; p < 0.001). Furthermore, ANG-1 levels
were significantly lower in those with SM compared to
individuals with either UM or CM, and in individuals
with CM compared to UM (Figure 1B; p < 0.001). Since
ANG-2 and ANG-1 have divergent roles in vascular activa-
tion, the ratio of ANG-2:ANG-1 was used as an additional
measure for each patient. This ratio was significantly
higher in patients with SM or CM compared to those with
UM (Figure 1C; p < 0.001).
Receiver operating characteristic (ROC) curves indicate 
that angiopoietin levels discriminate between UM and SM 
or CM
ROC curves were plotted for ANG-2, ANG-1, and the ratio
of ANG-2:ANG-1 to assess the ability of each biomarker to
discriminate between UM, SM and CM. Comparing indi-
viduals with UM vs. individuals with SM, all markers have
an area under the curve (AUC) that differs significantly
from that of a chance result (AUC: 0.5) (Figure 1D: AUC,
p-value: ANG-2, 0.763, p < 0.001; ANG-1, 0.884, p <
0.001; Ratio, 0.857, p < 0.001). Similarly, all markers dis-
criminated between UM and CM (Figure 1E: AUC, p-
value: ANG-2, 0.772, p < 0.001; ANG-1, 0.778, p < 0.001;
Ratio, 0.820, p < 0.001). Finally, ANG-1 but not ANG-2 or
the ANG-2:ANG-1 ratio, was able to discriminate between
SM and CM (Figure 1F: AUC, p-value: ANG-1; 0.735, p <
0.001: ANG-2; 0.527, p = 0.663: Ratio; 0.599, p = 0.084)
with ANG-1 levels being lower in SM than CM. In this
population, ANG-1 discriminated between UM and
severe malarial syndromes better than either ANG-2 or the
ratio of ANG-2:ANG-1, and was able to distinguish SM
from CM.
The ratio of ANG-2:ANG-1 displays high sensitivity and 
specificity as a biomarker for disease severity
The sensitivity, specificity, and positive and negative like-
lihood ratios (LR(±)) were determined for ANG-1, ANG-
2, and the ratio of ANG-2:ANG-1. Based on sensitivity and
specificity, ANG-1 was best able to discriminate between
UM and SM (cut-off (12.38 ng/mL): sensitivity: 0.861,
specificity: 0.857, LR(+): 6.028, LR(-): 0.162)); whereas
ANG-2 was better at discriminating between UM and CM
(cut-off (1.33 ng/mL): sensitivity: 0.759, specificity:
0.771, LR(+): 3.319, LR(-): 0.313)). The ratio of ANG-
2:ANG-1 was best at discriminating between complicated
disease of mixed phenotype (SM+CM) (cut-off 0.08): sen-
sitivity: 0.789, specificity: 0.829, LR(+): 4.60, LR(-):
0.264)) (Table 2). Collectively, our data suggest that the
ratio of ANG-2:ANG-1 may be the best predictor of
patients with uncomplicated disease versus patients with
complicated (severe or cerebral) disease, whereas ANG-1
may have utility in differentiating between cerebral
malaria vs. severe (non-cerebral) disease.
Table 1: Demographic characteristics of Thai adults with malaria
Uncomplicated Malaria Severe Malaria
(Non-cerebral)
Severe Malaria
(Cerebral)
P
Sample size 70 36 87
Sex, Number (%)
Male 46 (80) 27 (75) 73 (84)
Female 14 (20) 9 (25) 14 (16) 0.508a
Age, years 26 (13-50) 24 (14-59) 26 (14-61) 0.184 b
Parasitaemia, Parasites/uL 5360 (422385) 119850 (943890) 84840 (1188626) < 0.0001b
NOTE: Data are median (range) unless otherwise indicated.
a Chi-squared test.
b Kruskall-Wallis U test.
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Angiopoietins predict severe malaria independently of 
covariates
In order to examine whether endothelial activation was
independent of parasite burden, levels of ANG-1 and
ANG-2 were correlated with parasitaemia. Overall, there
was a positive correlation between ANG-2 and parasitae-
mia (Spearman's rho 0.339, p < 0.0001) and a negative
correlation between ANG-1 and parasitaemia (Spear-
man's rho -0.446, p < 0.0001). Furthermore, ANG-2 and
ANG-1 were negatively correlated with one another
(Spearman's rho -.320, p < 0.0001). Multivariate logistic
regression analysis revealed that the observed differences
in ANG levels between groups remained even after adjust-
ing for differences due to ethnicity, age, gender, and para-
sitaemia. There remained a significant increase in ANG-2
(and the ratio of ANG-2:ANG-1) in SM vs. UM, and CM
vs. UM, with no significant difference between SM and
CM. For ANG-1, there was a significant decrease in SM vs.
UM, CM vs. UM, and SM vs. CM (p < 0.0001).
Angiopoietin-2 is associated with cumulative organ injury
To address whether ANG levels are a measure of disease
severity, an organ injury score ranging from 0-5 was
assigned to each participant based on the number of
organ systems involved. A value of 1 was added to the
organ injury score for each participant based on the pres-
ence of each of the following: acute renal failure requiring
haemodialysis, clinically apparent jaundice, severe anae-
mia requiring a blood transfusion, circulatory collapse
with a systolic pressure <80 mmHg, and coma. ANG-2
and the ratio of ANG-2: ANG-1 were positively correlated
with cumulative organ injury (Spearman's rho, p-value:
Comparison of angiopoietin-1 and -2 levels in whole blood samples from Thai adults with malariaFigure 1
Comparison of angiopoietin-1 and -2 levels in whole blood samples from Thai adults with malaria. A-C. Whole 
blood concentrations of (A) angiopoietin-2 (ANG-2), (B) angiopoietin-1 (ANG-1), and (C) the ratio of ANG-2:ANG-1 (Ratio, 
expressed as log base 10) were measured in 70 uncomplicated malaria (UM) patients, 36 severe malaria (SM) patients, and 87 
cerebral malaria (CM) patients. ***p < 0.0001 by Kruskal-Wallis test with posthoc comparisons using Mann-Whitney U test 
and Bonferonni correction. D-F. Receiver operating characteristic (ROC) curves were generated for each test to compare (D) 
UM with SM patients, (E) UM with CM patients, and (F) SM with CM patients, with the null hypothesis (diagonal line) that the 
area under the curve equals 0.5.
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ANG-2; 0.378, p < 0.0001: ANG-2:ANG-1 ratio; 0.288, p
= 0.001). Interestingly, ANG-1 also trended towards a pos-
itive correlation (Spearman's rho 0.166, p = 0.071)
despite its ability to discriminate between individuals
with cerebral vs. severe non-cerebral malaria. To investi-
gate this further, a post-hoc analysis was performed to
examine how ANG-1 correlated with the organ systems
included in the analysis. There were no associations
observed between ANG-1 levels in participants with
hepatic dysfunction, severe anaemia or circulatory col-
lapse, although the latter was underpowered. However,
ANG-1 was positively associated with renal dysfunction
(Spearman's rho, p-value: 0.243, p = 0.007) and coma
(Spearman's rho, p-value: 0.370, p < 0.0001).
Discussion
These results demonstrate that whole blood ANG-1 and
ANG-2 levels are robust biomarkers of severe and cerebral
malaria. ANG-2, ANG-1 and the ratio of ANG-2: ANG-1
were significantly different between UM and both SM and
CM (Figure 1A-C). Of particular interest, ANG-1 levels fur-
ther distinguished patients with severe (non-cerebral)
malaria from those with cerebral involvement (Figure
1B). Finally, ROC curve analysis indicated good diagnos-
tic accuracy for these biomarkers in discriminating
uncomplicated malaria from severe malarial syndromes
(Figure 1D-F; Table 2). Significant differences between
groups remained after correcting for potential confound-
ing factors, and were independent of parasitaemia, ethnic-
ity, age and gender. Taken together with recent studies,
these data implicate dysregulation of angiopoietins in the
pathogenesis of complicated malaria and suggest they
may be clinically informative biomarkers of disease sever-
ity [8,11].
The ability of angiopoietins to discriminate between
uncomplicated and complicated malaria has now been
confirmed in three distinct geographic regions and popu-
Table 2: Optimal biomarker cut-off values for receiver operating characteristic curve sensitivity, specificity, positive likelihood ratio 
(LR(+)) and negative likelihood ratio (LR(-)) at the chosen cutoffs.
Cut-off Sensitivity Specificity LR(+) LR(-)
Angiopoietin-2 ng/mL #
(95% CI)
#
(95% CI)
#
(95% CI)
#
(95% CI)
UM vs. SM 1.43 0.694
(0.531-0.820)
0.786
(0.676-0.866)
3.241
(1.969-5.333)
0.389
(0.234-0.646)
UM vs. CM 1.33 0.759
(0.659-0.836)
0.771
(0.661-0.854)
3.319
(2.124-5.186)
0.313
(0.211-0.464)
UM vs. (CM+SM) 1.33 0.740
(0.656-0.809)
0.771
(0.661-0.854)
3.237
(2.078-5.041)
0.337
(0.244-0.466)
SM vs. CM 3.14 0.472
(0.319-0.630)
0.644
(0.539-0.736)
1.325
(0.848-2.070)
0.820
(0.580-1.159)
Angiopoietin-1 ng/mL #
(95% CI)
#
(95% CI)
#
(95% CI)
#
(95% CI)
UM vs. SM 12.38 0.861
(0.713-0.939)
0.852
(0.757-0.921)
6.028  (3.346-  10.859) 0.162
(0.071-0.368)
UM vs. CM 15.86 0.713
(0.610-0.797)
0.743
(0.630-0.831)
2.771
(1.821-4.218)
0.387
(0.270-0.554)
UM vs. (CM+SM) 15.16 0.707
(0.622-0.781)
0.771
(0.661-0.854)
3.094
(1.983-4.830)
0.379 
(0.280-0.514)
SM vs. CM 11.21 0.722
(0.560-0.842)
0.655
(0.551-0.747)
2.094
(1.471-2.982)
0.424
(0.245-0.734)
Ratio #
(95% CI)
#
(95% CI)
#
(95% CI)
#
(95% CI)
UM vs. SM 0.082 0.806
(0.650-0.903)
0.829
(0.724-0.899)
4.699
(2.74-8.059)
0.235
(0.120-0.460)
UM vs. CM 0.080 0.782
(0.684-0.856)
0.829
(0.724-0.899)
4.559
(2.692-7.722)
0.264
(0.175-0.398)
UM vs. (CM+SM) 0.080 0.789
(0.708-0.852)
0.829
(0.723-0.899)
4.600
(2.727-7.762)
0.255
(0.178-0.365)
SM vs. CM 0.448 0.444
(0.295-0.604)
0.828
(0.735-0.893)
2.578
(1.432-4.639)
0.671
(0.494-0.913)
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lations (children in Uganda, adults in Papua and Thai-
land). These proteins have previously been measured in
serum (ANG-1, ANG-2) [8], plasma (ANG-2) [11], and
here we show that they can be measured directly in whole
blood samples acquired from an independent population
of malaria-infected individuals. Only a small number of
patients progress to severe and fatal malaria [1,2] and a
rapid point-of-care test to identify malaria-infected indi-
viduals with or at risk of progressing to severe disease
could be of clinical utility. ANG-1 and ANG-2 are attrac-
tive candidates for incorporation into rapid lateral flow
immunochromatographic tests combined with malaria
antigen detection due to their detection in whole blood
and ability to discriminate between patients with and
without severe disease. However, before biomarkers like
ANG-1 or ANG-2 can be incorporated into rapid malaria
tests and clinical practice, additional prospective studies
will be needed to confirm and validate their usefulness in
different populations. Optimal cut-offs need to be deter-
mined using standardized methods of sample collection,
processing, and laboratory protocols for biomarker test-
ing.
ANG-1 and ANG-2 are stable proteins able to withstand
repeated freeze thaws without significant changes in pro-
tein levels, and are readily detectable, as this study dem-
onstrates, in whole blood. Furthermore, the
angiopoietins, which are linked with inflammation, ang-
iogenesis, and endothelial function and integrity, play a
central role in many of the disease processes implicated in
the pathogenesis of severe malarial syndromes. ANG-2
exists pre-stored within WP bodies and is rapidly released
upon, and may further contribute to, endothelial activa-
tion [12]. As a result, changes in ANG-2 levels may repre-
sent early changes in the endothelial beds, and future
studies should examine its utility as a predictive biomar-
ker. Furthermore, different endothelial beds may be dif-
ferentially responsive to exogenous stimuli, providing a
putative mechanism to explain why certain syndromes of
organ dysfunction are more common in severe malaria,
particularly acute renal injury, respiratory distress, or cer-
ebral malaria. This may be particularly relevant with ANG-
1, which differentiated between severe (non-cerebral)
malaria and cerebral malaria in this study.
In the current study, ANG-2 levels were elevated in severe
malarial syndromes compared to uncomplicated malaria
but were also correlated with scores of cumulative organ
injury in the cohort of severe malaria patients. This con-
firms other studies suggesting that ANG-2 is a marker of
disease severity in conditions associated with endothelial
activation [8,11,13,14]. However, this is the first study to
show that ANG-1 differentiates between severe (non-cere-
bral) and cerebral malaria. Interestingly, ANG-1 levels did
not correlate significantly with the cumulative organ
injury score but were specifically correlated with renal dys-
function and coma. It is unclear whether the association
between ANG-1 levels and the presence of renal impair-
ment and coma are due to the nature of microvascular
environment in those organ systems or other physiologi-
cal derangements. In order to address those questions,
these observations will need to be confirmed in a larger
population of individuals with well-characterized clinical
phenotypes.
The use of biomarkers is inherently limited by their specif-
icity for the disease in question. Dysregulation of angi-
opoietins may occur in a number of severe infectious
syndromes associated with endothelial activation and
dysfunction. As a result, it will be important to consider
the implications of co-infections, including bacterial and
viral (e.g. HIV) infections if these proteins are to be used
as prognostic indicators for malaria.
Finally, based on our study design it was not possible to
examine the predictive value of angiopoietins and future
prospective studies are needed to examine the kinetics of
angiopoietin levels and their relation to symptom onset,
clinical history of malaria, and response to treatment.
However, should angiopoietins fail to distinguish
between malaria and other infectious diseases, these pro-
teins may still be informative biomarkers to facilitate clin-
ical decision-making (e.g. patient triage, referral,
admission) and optimal allocation of health resources for
the treatment of severe infections associated with
endothelial dysfunction.
Conclusions
In summary, these data suggest that ANG-1 and ANG-2
are promising biomarkers of severe malaria. Furthermore,
the ability to robustly detect angiopoietin levels in whole
blood makes them attractive candidates for potential inte-
gration into point-of-care diagnostic/theranostic devices
of disease severity.
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